- Home
- APLT vs TRNS Comparison
APLT vs TRNS Comparison
Compare APLT & TRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- TRNS
- Stock Information
- Founded
- APLT 2016
- TRNS 1964
- Country
- APLT United States
- TRNS United States
- Employees
- APLT N/A
- TRNS N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- TRNS Electrical Products
- Sector
- APLT Health Care
- TRNS Industrials
- Exchange
- APLT Nasdaq
- TRNS Nasdaq
- Market Cap
- APLT 971.6M
- TRNS 1.1B
- IPO Year
- APLT 2019
- TRNS N/A
- Fundamental
- Price
- APLT $8.69
- TRNS $103.42
- Analyst Decision
- APLT Strong Buy
- TRNS Strong Buy
- Analyst Count
- APLT 5
- TRNS 4
- Target Price
- APLT $12.50
- TRNS $119.75
- AVG Volume (30 Days)
- APLT 1.8M
- TRNS 102.8K
- Earning Date
- APLT 11-07-2024
- TRNS 10-28-2024
- Dividend Yield
- APLT N/A
- TRNS N/A
- EPS Growth
- APLT N/A
- TRNS 77.19
- EPS
- APLT N/A
- TRNS 1.98
- Revenue
- APLT N/A
- TRNS $270,612,000.00
- Revenue This Year
- APLT N/A
- TRNS $9.56
- Revenue Next Year
- APLT $3,169.03
- TRNS $6.00
- P/E Ratio
- APLT N/A
- TRNS $52.26
- Revenue Growth
- APLT N/A
- TRNS 11.42
- 52 Week Low
- APLT $1.79
- TRNS $89.74
- 52 Week High
- APLT $10.62
- TRNS $147.12
- Technical
- Relative Strength Index (RSI)
- APLT 46.34
- TRNS 38.56
- Support Level
- APLT $9.44
- TRNS $105.23
- Resistance Level
- APLT $10.62
- TRNS $110.59
- Average True Range (ATR)
- APLT 0.62
- TRNS 4.46
- MACD
- APLT -0.13
- TRNS 0.43
- Stochastic Oscillator
- APLT 14.95
- TRNS 45.27
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About TRNS Transcat Inc.
Transcat Inc is involved in providing calibration and laboratory instrument services and distribution of test, measurement, and control instrumentation. Its product and services portfolio consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, etc. The firm has Service and Distribution operating segments. It derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Estech, FLIR, Fluke, Keysight, and Megger among others. It serves to pharmaceutical, industrial manufacturing, energy, and chemical process industries.